Cochaud et al. (7) observed increased infiltration of IL-17A-positive cells in ER-negative breast cancer than in ER-positive breast cancer on the basis of immunohistochemistry analysis in 40 breast cancer cases. This evidence concerns the gene IL17A and breast carcinoma.